A new research report by Transparency Market Research offers a comprehensive study of the global clinical chemistry analyzers market. The market report, titled “Clinical Chemistry Analyzers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023”, is available for sale on the firm’s website.

According to the report, the rising awareness regarding healthcare and diagnostic tests among people has driven the worldwide market for clinical chemistry analyzers significantly. The rise in healthcare expenditure in developed economies has also been an important driver for this market so far. In addition to this, the augmenting trend of laboratory automation, as well as the increasing number of reagent rental agreements, is likely to fuel this market over the forecast period.

Get Report Sample and Customization: 
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5366

The report studies the global clinical chemistry analyzers market on the basis of sector, product, test type, end user, and regional spread. Based on sector, the study segments the global market into large sector analyzers, ultra-large sector analyzers, mid sector analyzers, and small sector analyzers. By test type, the market has been classified into liver panels, thyroid function panels, electrolyte panels, basic metabolic panels, lipid profiles, and renal profiles in this report.

Product-wise, the study describes analyzers, reagents, and other products as the key segments of this market. Hospitals, academic research institutes, diagnostic laboratories, and other medical and healthcare institutions have been determined as the prime end users of clinical chemistry analyzers across the world.

Regionally, the global clinical chemistry analyzers market has been divided into Europe, North America, Asia Pacific, and the Rest of the World in this study.

North America has occupied the leading position among all the regional markets for clinical chemistry analyzers in recent years. However, analysts at TMR expect the Asia Pacific clinical chemistry analyzers market to surpass the market in North America and register the highest growth rate over the forecast period. The expansion of the clinical diagnostics segment in Asia Pacific, resulting in the maturity of the clinical chemistry analyzers market in this region, is projected to be the main driving force behind this rise.

Currently, the markets for clinical chemistry analyzers in the U.S., Japan, and Europe collectively hold a share of more than 60% in the global market, says the research study.

The market study also presents an overview of the competitive landscape of the global clinical chemistry analyzers market based on an analysis of the company profiles of major participants. As per the report, this market is extremely fragmented in nature.

Nova Biomedical Corp., Beckman Coulter Inc., Abbott Diagnostics, Thermo Fisher Scientific Inc., Siemens AG, Johnson and Johnson, Mindray Medical International Ltd., Elitech Group, Horiba Ltd., Sysmex Corp., and Ortho-Clinical Diagnostics Inc. are some of the key companies operating in this market, states the research report.

Full Research Report on Global Clinical Chemistry Analyzers Market with detailed figures and segmentation at: http://www.transparencymarketresearch.com/clinical-chemistry-analyzers-market.html